The Role of Selenium During Gestation in the Development of Fetal Congenital Anomalies: A Systematic Review
Nutrients · 2026
DOI: 10.3390/nu18030479 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Nutrients, 2026. Verfasst von Nikolina Stachika und 6 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Obstetrics and Gynecology, "Aretaieion" University Hospital, Medical School, National and Kapodistrian University of Athens, 115…. Hauptthemen laut MEDLINE: Congenital Abnormalities, Selenium. Die Arbeit nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: During intrauterine development, cell proliferation, differentiation, and apoptosis are strictly regulated for organogenesis to be ensured; disruption of these processes, e.g., by oxidative stress, may lead to congenital anomalies. This systematic review aimed to examine the role of selenium (Se), an important antioxidant, during gestation in the development of congenital anomalies.
Methods
To identify relevant original research studies in English, PubMed, Embase, and Cochrane Library were systematically searched up to December 2025. A qualitative synthesis, quality appraisal, and assessment of predefined sources of bias and heterogeneity were performed.
Results
2743 titles and abstracts were screened, 473 full texts assessed, and 31 papers included. Selenium exposure did not affect the risk of all/any congenital anomalies (n = 20,815), abdominal (n = 89,273) and limb anomalies (n = 551,547), chromosomal anomalies (n = 1242), or fetal alcohol syndrome (n = 41). Higher concentrations of Se were associated with increased risk for urinary tract anomalies (n = 2150), but decreased risk for congenital heart defects (n = 1807), neural tube defects (max n = 12,188), and orofacial clefts (max n = 1155).
Conclusions
Available scientific evidence arises from observational studies and is prone to confounding mainly by gestational age, while only one randomized controlled trial has been identified. Given the major contribution of congenital anomalies to neonatal morbidity, mortality, and long-term impairment of quality of life, well-designed prospective studies are required to establish scientific consensus, define optimal maternal Se levels during pregnancy, and provide evidence-based recommendations for Se supplementation during pregnancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Second Department of Obstetrics and Gynecology, "Aretaieion" University Hospital, Medical School, National and Kapodistrian University of Athens, 115 28 Athens, Greece.
- Third Department of Obstetrics and Gynecology, University General Hospital "ATTIKON", Medical School, National and Kapodistrian University of Athens, 124 62 Athens, Greece.
ORCID-Profile: Nikolina Stachika, Ermioni Tsarna, Christina Dalla, Anastasios Potiris, Panagiotis Christopoulos
Zitieren
APA
Stachika, N., Tsarna, E., Kyriakou, S. I., Dalla, C., Potiris, A., Stavros, S., & Christopoulos, P. (2026). The Role of Selenium During Gestation in the Development of Fetal Congenital Anomalies: A Systematic Review. Nutrients. https://doi.org/10.3390/nu18030479
Vancouver
Stachika N, Tsarna E, Kyriakou SI, Dalla C, Potiris A, Stavros S, et al. The Role of Selenium During Gestation in the Development of Fetal Congenital Anomalies: A Systematic Review. Nutrients. 2026. doi:10.3390/nu18030479
BibTeX
@article{Stachika2026,
author = {Stachika, Nikolina and Tsarna, Ermioni and Kyriakou, Stavroula-Ioanna and Dalla, Christina and Potiris, Anastasios and Stavros, Sofoklis and Christopoulos, Panagiotis},
title = {The Role of Selenium During Gestation in the Development of Fetal Congenital Anomalies: A Systematic Review},
journal = {Nutrients},
year = {2026},
doi = {10.3390/nu18030479}
}
EUVIMED